O. Rimoldi et al., Measurement of myocardial blood flow with positron emission tomography before and after transmyocardial laser revascularization, CIRCULATION, 100(19), 1999, pp. 134-138
Citations number
32
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background-Transmyocardial laser revascularization (TMLR) has been proposed
for treatment of refractory angina. It has been hypothesized that transmur
al left ventricular channels created by laser improve myocardial blood flow
(MBF) in the treated zones. We aimed to assess the effect of TMLR on MBF a
nd coronary vasodilator reserve (CVR).
Methods and Results-We measured MBF by means of PET with O-15-labeled water
in 7 patients with refractory angina, Canadian Cardiovascular Society (CCS
) class 3.6+/-0.5, on 3 occasions: before and at 7.5+/-2.8 weeks (FU-1) and
34.6+/-4.7 weeks (FU-2) after TMLR performed with a synchronized, high-pow
ered CO2 laser. In each study, MBF was measured at rest and during maximal
intravenous dobutamine, CVR was computed as dobutamine divided by resting M
BF. After TMLR, CCS class was 2.2+/-1.7 at FU-1 and 2.4+/-1 at FU-2 (P=0.04
versus pre-TMLR). Resting MBF in both lasered and nonlasered regions was u
nchanged after TMLR. Dobutamine MBF at baseline was 1.45+/-0.52 and 1.55+/-
0.52 mL.min(-1).g(-1) in lasered and nonlasered regions, respectively (P=NS
), At FU-I, dobutamine MBF in nonlasered regions had increased significantl
y to 1.89+/-0.82 mL. min(-1). g(-1) (P<0.05) and was higher than in lasered
regions (1.51+/-0.61 mL. min(-1). g(-1); P<0.05 versus nonlasered). At FU-
2, dobutamine MBF in nonlasered regions was still higher than in lasered re
gions (1.56+/-0.54 versus 1.21+/-0.72 mL. min(-1). g(-1); P<0.01). CVR was
comparable in nonlasered and lasered regions at baseline and FU-1, whereas
it was higher in nonlasered regions at FU-2 (1.86+/-0.67 versus 1.53+/-0.72
mL. min(-1). g(-1); P<0.05),
Conclusions-TMLR has been shown to reduce angina in severely diseased patie
nts. The results of our study do not support the hypothesis that the sympto
matic benefit of TMLR can be ascribed to improved myocardial perfusion or C
VR in lasered areas.